英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

accusative    音标拼音: [əkj'uzətɪv]
a. 直接受格的
n. 宾格

直接受格的宾格

accusative
adj 1: containing or expressing accusation; "an accusitive
forefinger"; "black accusatory looks"; "accusive shoes
and telltale trousers"- O.Henry; "his accusing glare"
[synonym: {accusative}, {accusatory}, {accusing}, {accusive}]
2: serving as or indicating the object of a verb or of certain
prepositions and used for certain other purposes; "objective
case"; "accusative endings" [synonym: {objective}, {accusative}]
n 1: the case of nouns serving as the direct object of a verb
[synonym: {accusative}, {accusative case}, {objective case}]

Accusative \Ac*cu"sa*tive\, a. [F. accusatif, L. accusativus (in
sense 2), fr. accusare. See {Accuse}.]
[1913 Webster]
1. Producing accusations; accusatory. "This hath been a very
accusative age." --Sir E. Dering.
[1913 Webster]

2. (Gram.) Applied to the case (as the fourth case of Latin
and Greek nouns) which expresses the immediate object on
which the action or influence of a transitive verb
terminates, or the immediate object of motion or tendency
to, expressed by a preposition. It corresponds to the
objective case in English.
[1913 Webster]


Accusative \Ac*cu"sa*tive\, n. (Gram.)
The accusative case.
[1913 Webster]

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Treating Squamous Cell Carcinoma | Squamous Cell Cancer . . .
    Treating advanced squamous cell cancers Different types of treatments might be used for SCCs that have spread beyond the skin Lymph node dissection: Removing regional (nearby) lymph nodes might be recommended for some SCCs that are very large or have grown deeply into the skin, as well as if the lymph nodes feel enlarged and or hard
  • LIBTAYO® (cemiplimab-rwlc) in Advanced NSCLC, BCC, CSCC . . .
    LIBTAYO is a prescription medicine used to treat adults with a type of skin cancer called basal cell carcinoma (BCC) when your BCC cannot be removed by surgery (locally advanced BCC) or when it has spread (metastatic BCC) and have previously received treatment with a hedgehog pathway inhibitor (HHI), or cannot receive treatment with a HHI
  • Cemiplimab-rwlc (Libtayo®) - OncoLink
    About Cemiplimab-rwlc (Libtayo®) The immune system works by creating antibodies, which are proteins that attach to antigens found on the surface of a cell The antibody “calls” the immune system to attack the cell it is attached to, resulting in the immune system killing the cell Monoclonal antibodies are created in a lab to attach to the antigens found on specific types of cancer cells
  • Libtayo: Uses, Side Effects, Warnings - Drugs. com
    Libtayo (cemiplimab-rwlc) is used to treat metastatic cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer Includes Libtayo side effects, interactions and indications
  • LIBTAYO® Full Prescribing Information | Regeneron
    1 3 Non-Small Cell Lung Cancer LIBTAYO in combination with platinum-based chemotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (NSCLC) with no EGFR, ALK or ROS1 aberrations and is:
  • Cemiplimab-rwlc (Libtayo) Updates 2025: Uses in cancer, Side . . .
    This article is about Cemiplimab-rwlc (Libtayo), its uses, side effects, dosage, and what to expect during treatment
  • label - accessdata. fda. gov
    1 3 Non-Small Cell Lung Cancer LIBTAYO in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with non-small cell lung cancer (NSCLC) with no EGFR, ALK or ROS1 aberrations and is:
  • Cemiplimab (Libtayo®) - ChemoExperts
    Treatment Name: Cemiplimab (Libtayo®) Cemiplimab (Libtayo®) is an Immunotherapy Regimen for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC) How does cemiplimab work? Cemiplimab is designed to block the signals that tumor cells use to suppress the immune system allowing the immune system to attack the lung cancer cells Goals of therapy:
  • Cemiplimab (Libtayo Regeneron) - Guidelines+ Monographs
    Libtayo is a programmed death receptor-1 (PD-1) blocking antibody indicated for the treatment of patients with metastatic cutaneous squamous cell carcinoma (mCSCC), locally advanced or metastatic basal cell carcinoma (laBCC or mBCC), and non-small cell lung cancer (NSCLC) It was initially approved in 2018
  • What Libtayo Means for High-Risk Cutaneous Squamous Cell . . .
    Key Takeaways Libtayo's FDA approval offers an effective adjuvant option for high-risk cutaneous squamous cell carcinoma, reducing recurrence risk by 68% in the C-POST trial Administered post-surgery and radiation, Libtayo prevents recurrence rather than treating existing tumors, with a safety profile consistent with advanced cancer use





中文字典-英文字典  2005-2009